Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Neurotrophic and cognition-enhancing effects reported for TEI-3356 this week in Yokohama

March 24, 2000

Sigma1-receptor confirmed as site of action for antipsychotic MS-377

March 24, 2000

SB reveals more novel anticonvulsants with affinity for novel binding site

March 24, 2000

U.K. virtual drug development company adds another product to its pipeline

March 24, 2000

Abbott and NPS establish agreement for NPS-1776

March 24, 2000

Merck compound L-754030 and use in circadian rhythm disorders covered by new patent

March 23, 2000

Abeta peptide formation inhibitors from Roche for the treatment of AD

March 23, 2000

Novel lactams prepared at DuPont inhibit Abeta-peptide production

March 22, 2000

Known antiallergic agent from Kyorin now claimed for use in MS

March 22, 2000

SB adds another anticonvulsant series to its pipeline

March 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...